Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-03-14 Sale | 2022-03-14 9:21 pm | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 1,657 | $5.5973 | $9,275 | 60,468 (Direct) | View |
2022-01-07 Sale | 2022-01-11 8:59 pm | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 1,560 | $4.9501 | $7,722 | 46,125 (Direct) | View |
2021-01-08 Sale | 2021-01-11 6:10 pm | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 1,690 | $11.68 | $19,739 | 35,810 (Direct) | View |
2020-01-24 Purchase | 2020-01-30 4:44 pm | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 5,000 | $13.52 | $67,603 | 30,000 (Direct) | View |
2018-11-29 Purchase | 2018-11-30 2:26 pm | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Director | 4,000 | $10.21 | $40,840 | 25,000 (Direct) | View |
2018-11-26 Purchase | 2018-11-28 8:51 pm | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Director | 21,000 | $9.9046 | $207,998 | 21,000 (Direct) | View |
2018-09-10 Purchase | 2018-09-12 7:48 pm | RIGEL PHARMACEUTICALS INC | RIGL | Mayer Eldon C. III EVP & Chief Commercial Officer | 100,000 | $3.2555 | $325,550 | 215,000 (Direct) | View |
2018-08-23 Purchase | 2018-08-27 7:49 pm | RIGEL PHARMACEUTICALS INC | RIGL | Mayer Eldon C. III EVP & Chief Commercial Officer | 100,000 | $2.8232 | $282,320 | 115,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-01-26 Option Award | 2023-01-30 9:25 pm | N/A 2033-01-26 | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 31,500 | $0 | 31,500 (Direct) | View |
2022-03-11 Option Award | 2022-03-11 9:06 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 114,000 | $0 | 160,125 (Direct) | View |
2021-07-29 Option Award | 2021-07-30 4:32 pm | N/A 2031-07-28 | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 17,500 | $0 | 17,500 (Direct) | View |
2021-03-12 Option Award | 2021-03-15 7:31 pm | N/A 2031-03-11 | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 83,125 | $0 | 118,935 (Direct) | View |
2020-01-31 Option Award | 2020-01-31 7:33 pm | N/A 2030-01-30 | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 157,500 | $0 | 187,500 (Direct) | View |
2019-11-18 Option Award | 2019-11-20 8:15 pm | N/A 2028-01-24 | RIGEL PHARMACEUTICALS INC | RIGL | Mayer Eldon C. III EVP & Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
2019-03-21 Option Award | 2019-03-25 10:00 pm | N/A 2029-03-20 | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Director | 10,000 | $0 | 10,000 (Direct) | View |
2019-03-20 Option Award | 2019-03-22 7:23 pm | N/A 2028-01-24 | RIGEL PHARMACEUTICALS INC | RIGL | Mayer Eldon C. III EVP & Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
2019-01-23 Option Award | 2019-01-25 6:36 pm | N/A 2029-01-23 | RIGEL PHARMACEUTICALS INC | RIGL | Mayer Eldon C. III EVP & Chief Commercial Officer | 200,000 | $0 | 200,000 (Direct) | View |
2018-05-09 Option Award | 2018-05-11 7:47 pm | N/A 2027-02-02 | RIGEL PHARMACEUTICALS INC | RIGL | Mayer Eldon C. III EVP & Chief Commercial Officer | 50,000 | $0 | 50,000 (Direct) | View |
2018-03-14 Option Award | 2018-03-16 8:24 pm | N/A 2028-03-13 | Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Director | 10,000 | $0 | 10,000 (Direct) | View |